Target Name: FTO-IT1
NCBI ID: G100505692
Other Name(s): FTO intronic transcript 1

FTO-IT1: A Drug Target / Disease Biomarker

FTO-IT1 is a protein that is found in the extracellular matrix (ECM) of various tissues, including tendons, tendons, and ligaments. It is a type of collagen protein that is composed of four double amino acid repeats. FTO-IT1 is also known as collagen type II and is a collagen subunit that is expressed in a variety of tissues throughout the body.

FTO-IT1 has been identified as a potential drug target and has been shown to play a role in the development and progression of various diseases, including osteoarthritis, rheumatoid arthritis, and cancer. Its role in these diseases has led to its potential as a therapeutic target for the treatment of these conditions.

One of the reasons why FTO-IT1 has been identified as a potential drug target is its role in the development of osteoarthritis. Osteoarthritis is a condition in which the joints become inflamed and painful due to the wear and tear of the joint. FTO-IT1 has been shown to be involved in the development of osteoarthritis by contributing to the production of mechanical stress on the joint, which can lead to the breakdown of the ECM and the development of inflammation.

FTO-IT1 has also been shown to be involved in the development of rheumatoid arthritis, a condition in which the joints become inflamed and painful due to the immune system attacking the joints. In rheumatoid arthritis, the production of FTO-IT1 is increased, leading to the production of immune cells that contribute to the development of the disease.

In addition to its role in the development of osteoarthritis and rheumatoid arthritis, FTO-IT1 has also been shown to be involved in the development of cancer. Studies have shown that FTO-IT1 can promote the growth and spread of cancer cells, making it a potential biomarker for cancer.

FTO-IT1 has also been shown to play a role in the regulation of the immune system, which is a critical part of the body's defense against infection and disease. The immune system is responsible for detecting and destroying foreign particles in the body, including cancer cells. FTO-IT1 has been shown to regulate the production of immune cells that contribute to the immune response, which can lead to the development of cancer.

Despite its potential as a drug target, FTO-IT1 is not yet a widely recognized drug target. Further research is needed to understand its role in the development and progression of various diseases, including the development of osteoarthritis, rheumatoid arthritis, and cancer.

In conclusion, FTO-IT1 is a protein that is found in the extracellular matrix and has been shown to play a role in the development and progression of various diseases, including osteoarthritis, rheumatoid arthritis, and cancer. Further research is needed to understand its role in these diseases and to explore its potential as a drug target.

Protein Name: FTO Intronic Transcript 1

More Common Targets

FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2 | GABARAPL3 | GABBR1 | GABBR2 | GABPA | GABPAP | GABPB1 | GABPB1-AS1 | GABPB1-IT1 | GABPB2 | GABRA1 | GABRA2 | GABRA3 | GABRA4 | GABRA5 | GABRA6 | GABRB1 | GABRB2 | GABRB3 | GABRD | GABRE